Impact of Tether Length on Bone Mineral Affinity of Protein-Bisphosphonate Conjugates

被引：0
|
作者：
Sébastien A. Gittens
Pavel I. Kitov
John R. Matyas
Raimar Löbenberg
Hasan Uludağ
机构：
[1] University of Alberta,Faculty of Pharmacy & Pharmaceutical Sciences
[2] University of Alberta,Department of Biomedical Engineering, Faculty of Medicine & Dentistry
[3] University of Alberta,Department of Chemistry, Faculty of Science
[4] University of Alberta,Department of Chemical & Materials Engineering, Faculty of Engineering
[5] University of Calgary,Department of Cell Biology & Anatomy, Faculty of Medicine
来源：
Pharmaceutical Research | 2004年 / 21卷
关键词：
bisphosphonates; bone binding; heterobifunctional crosslinkers; hydroxyapatite affinity; tether length.;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose. To determine the effect of tether length on bone mineral affinity of fetuin-bisphosphonate conjugates.
引用
收藏
页码：608 / 616
页数：8
相关论文
共 25 条
  • [1] Impact of tether length on bone mineral affinity of protein-bisphosphonate conjugates
    Gittens, SA
    Kitov, PI
    Matyas, JR
    Löbenberg, R
    Uludag, H
    PHARMACEUTICAL RESEARCH, 2004, 21 (04) : 608 - 616
  • [2] Imparting bone mineral affinity to osteogenic proteins through heparin-bisphosphonate conjugates
    Gittens, SA
    Bagnall, K
    Matyas, JR
    Löbenberg, R
    Uludag, H
    JOURNAL OF CONTROLLED RELEASE, 2004, 98 (02) : 255 - 268
  • [3] A comparison of mineral affinity of bisphosphonate-protein conjugates constructed with disulfide and thioether linkages
    Wright, JEI
    Gittens, SA
    Bansal, G
    Kitov, PI
    Sindrey, D
    Kucharski, C
    Uludag, H
    BIOMATERIALS, 2006, 27 (05) : 769 - 784
  • [4] Bone mineral affinity influences the distribution of a bisphosphonate and a lower affinity analogue in vivo
    Roelofs, A. J.
    Boyde, A.
    Lundy, M. W.
    McKenna, C. E.
    Blazewska, K.
    Sun, S. T.
    Kashemirov, B. A.
    Russell, R. G. G.
    Ebetino, F. H.
    Rogers, M. J.
    Coxon, F. P.
    BONE, 2009, 44 (02) : S430 - S431
  • [5] Bone affinity of a bisphosphonate-conjugated protein in vivo
    Uludag, H
    Gao, TJ
    Wohl, GR
    Kantoci, D
    Zernicke, RF
    BIOTECHNOLOGY PROGRESS, 2000, 16 (06) : 1115 - 1118
  • [6] IMPACT OF BISPHOSPHONATE TREATMENT ON BONE MINERAL DENSITY OF PATIENTS AFTER KIDNEY TRANSPLANTATION
    Georgopoulou, Georgia Andriana
    Papasotiriou, Marios
    Ntrinias, Theodoros
    Savvidaki, Eirini
    Goumenos, Dimitrios
    Papachristou, Evangelos
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [7] The differential distribution in vivo of fluorescently-labeled bisphosphonate analogues with different mineral affinity to bone surfaces
    Boyde, A.
    Lundy, M. W.
    Coxon, F. P.
    McKenna, C. E.
    Roelofs, A.
    Bala, J.
    Rogers, M. J.
    Blazewska, K.
    Russelle, R. G. G.
    Ebetino, F. H.
    BONE, 2009, 44 : S57 - S57
  • [8] Impact of Vitamin D, Bisphosphonate, and Combination Therapy on Bone Mineral Density in Kidney Transplant Patients
    Jeon, H.
    Han, M.
    Jeong, J.
    Kim, Y.
    Kwon, H.
    Koo, T.
    Kim, M.
    Ro, H.
    Ahn, C.
    Yang, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 67 - 67
  • [9] Impact of Vitamin D, Bisphosphonate, and Combination Therapy on Bone Mineral Density in Kidney Transplant Patients
    Jeon, H. J.
    Han, M.
    Jeong, J. C.
    Kim, Y. J.
    Kwon, H. Y.
    Koo, T. Y.
    Ahn, C.
    Yang, J.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (08) : 2963 - 2967
  • [10] Thermally Assisted Generation of Protein-Poly(ethylene sodium phosphate) Conjugates with High Mineral Affinity
    Noree, Susita
    Iwasaki, Yasuhiko
    ACS OMEGA, 2019, 4 (02): : 3398 - 3404
123